TTEC heads into its Q1 2026 earnings print today with a notable disconnect: short sellers are dug in, yet insiders spent months accumulating the stock at prices close to where it trades now.
Short interest is the dominant positioning story here. At 14.2% of free float — ranking in the bottom 1st percentile across the universe — nearly one share in seven is sold short. The ORTEX short score has stayed locked above 80 for the past two weeks, one of the more extreme readings across the market. Days to cover run to nearly 14, meaning shorts would need roughly two full weeks of average volume to unwind. Borrow costs are modest at 1.6% — down from above 2.6% in early April — and availability at 71% of short interest means the lending pool still has room. The short thesis is entrenched, but not facing a squeeze from the borrow side.
The insider signal runs directly against that positioning. Independent Director Marc Holtzman purchased 173,056 shares across four separate transactions in early March, spending roughly $420,000 at prices between $2.31 and $2.69. That cluster of buys — methodical, repeated, close in price — stands out against a 90-day net insider figure of approximately 187,000 shares acquired. The CFO received a stock award in February but sold a small portion to cover taxes — a routine pattern — leaving Holtzman's open-market buying as the cleanest signal of insider conviction. The founder and chairman, Kenneth Tuchman, remains the anchor with 57% of shares held and has not changed his position.
The analyst picture offers little resolution. Coverage is thin — one buy, three holds — and the most recent rating action was William Blair's downgrade to Market Perform in November 2025, six months ago. That consensus is stale enough to treat with caution. Canaccord's $3.50 target, set in March 2025, sits just above the current $3.06 price and implies negligible upside, consistent with a market that sees the name as optically cheap rather than attractively valued. Options positioning tilts bullish — the put/call ratio is just 0.056, well below its 20-day average of 0.074, and near the low end of its 52-week range. That confirms call-side dominance, though volumes in a micro-cap with a $145 million market cap should be read cautiously. The stock itself has staged a 27.5% recovery over the past month, clawing back ground from its March lows, though it remains down roughly 17.5% year-to-date.
The last two confirmed earnings reactions show the stock moving higher: up 7.2% on the day after the most recent print, and up 2.7% (then 23% over five days) the prior quarter. Today's release will test whether that momentum has enough fundamental backing — specifically, whether TTEC can demonstrate any stabilisation in revenue as AI-driven disruption continues to reshape the customer experience outsourcing industry it depends on.
See the live data behind this article on ORTEX.
Open TTEC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
